ID A7BFV9_RAT Unreviewed; 897 AA. AC A7BFV9; DT 11-SEP-2007, integrated into UniProtKB/TrEMBL. DT 11-SEP-2007, sequence version 1. DT 27-MAR-2024, entry version 89. DE SubName: Full=Epidermal growth factor receptor pathway substrate 15 {ECO:0000313|EMBL:BAF74783.1}; GN Name=Eps15 {ECO:0000313|RGD:1305550}; OS Rattus norvegicus (Rat). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Rattus. OX NCBI_TaxID=10116 {ECO:0000313|EMBL:BAF74783.1}; RN [1] {ECO:0000313|EMBL:BAF74783.1} RP NUCLEOTIDE SEQUENCE. RX PubMed=17626015; DOI=10.1074/jbc.M703815200; RA Uezu A., Horiuchi A., Kanda K., Kikuchi N., Umeda K., Tsujita K., RA Suetsugu S., Araki N., Yamamoto H., Takenawa T., Nakanishi H.; RT "SGIP1alpha is an endocytic protein that directly interacts with RT phospholipids and Eps15."; RL J. Biol. Chem. 282:26481-26489(2007). CC -!- INTERACTION: CC A7BFV9; O14526: FCHO1; Xeno; NbExp=2; IntAct=EBI-6095043, EBI-719823; CC A7BFV9; Q3UQN2: Fcho2; Xeno; NbExp=2; IntAct=EBI-6095043, EBI-6094986; CC A7BFV9; Q8VD37: Sgip1; Xeno; NbExp=4; IntAct=EBI-6095043, EBI-776269; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AB262963; BAF74783.1; -; mRNA. DR AlphaFoldDB; A7BFV9; -. DR IntAct; A7BFV9; 8. DR MINT; A7BFV9; -. DR iPTMnet; A7BFV9; -. DR PhosphoSitePlus; A7BFV9; -. DR AGR; RGD:1305550; -. DR RGD; 1305550; Eps15. DR GO; GO:0016235; C:aggresome; ISO:RGD. DR GO; GO:0030122; C:AP-2 adaptor complex; ISO:RGD. DR GO; GO:0016324; C:apical plasma membrane; IDA:RGD. DR GO; GO:0009925; C:basal plasma membrane; IDA:RGD. DR GO; GO:0060170; C:ciliary membrane; ISO:RGD. DR GO; GO:0030132; C:clathrin coat of coated pit; ISO:RGD. DR GO; GO:0005905; C:clathrin-coated pit; ISO:RGD. DR GO; GO:0030136; C:clathrin-coated vesicle; ISO:RGD. DR GO; GO:0005737; C:cytoplasm; IBA:GO_Central. DR GO; GO:0005829; C:cytosol; IEA:GOC. DR GO; GO:0005769; C:early endosome; IDA:RGD. DR GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO. DR GO; GO:0005886; C:plasma membrane; ISO:RGD. DR GO; GO:0098794; C:postsynapse; IEA:GOC. DR GO; GO:0045202; C:synapse; IDA:SynGO. DR GO; GO:0005509; F:calcium ion binding; IEA:InterPro. DR GO; GO:0042802; F:identical protein binding; ISO:RGD. DR GO; GO:0031593; F:polyubiquitin modification-dependent protein binding; ISO:RGD. DR GO; GO:0043130; F:ubiquitin binding; ISO:RGD. DR GO; GO:0048268; P:clathrin coat assembly; ISO:RGD. DR GO; GO:0032456; P:endocytic recycling; IMP:RGD. DR GO; GO:0006897; P:endocytosis; IBA:GO_Central. DR GO; GO:0016197; P:endosomal transport; IBA:GO_Central. DR GO; GO:0006895; P:Golgi to endosome transport; ISO:RGD. DR GO; GO:0001921; P:positive regulation of receptor recycling; IMP:RGD. DR GO; GO:0098884; P:postsynaptic neurotransmitter receptor internalization; IDA:SynGO. DR GO; GO:0019065; P:receptor-mediated endocytosis of virus by host cell; ISO:RGD. DR GO; GO:0042127; P:regulation of cell population proliferation; IMP:RGD. DR GO; GO:0032880; P:regulation of protein localization; ISO:RGD. DR GO; GO:0070086; P:ubiquitin-dependent endocytosis; ISO:RGD. DR GO; GO:0046718; P:viral entry into host cell; ISO:RGD. DR CDD; cd00052; EH; 3. DR Gene3D; 1.10.287.1490; -; 1. DR Gene3D; 1.10.238.10; EF-hand; 3. DR InterPro; IPR011992; EF-hand-dom_pair. DR InterPro; IPR018247; EF_Hand_1_Ca_BS. DR InterPro; IPR002048; EF_hand_dom. DR InterPro; IPR000261; EH_dom. DR InterPro; IPR003903; UIM_dom. DR PANTHER; PTHR11216; EH DOMAIN; 1. DR PANTHER; PTHR11216:SF54; EPIDERMAL GROWTH FACTOR RECEPTOR SUBSTRATE 15; 1. DR Pfam; PF12763; EF-hand_4; 3. DR SMART; SM00054; EFh; 4. DR SMART; SM00027; EH; 3. DR SMART; SM00726; UIM; 2. DR SUPFAM; SSF47473; EF-hand; 3. DR SUPFAM; SSF90257; Myosin rod fragments; 1. DR PROSITE; PS00018; EF_HAND_1; 2. DR PROSITE; PS50222; EF_HAND_2; 3. DR PROSITE; PS50031; EH; 3. DR PROSITE; PS50330; UIM; 2. PE 1: Evidence at protein level; KW Calcium {ECO:0000256|ARBA:ARBA00022837}; KW Coiled coil {ECO:0000256|SAM:Coils}; KW Metal-binding {ECO:0000256|ARBA:ARBA00022723}; KW Receptor {ECO:0000313|EMBL:BAF74783.1}. FT DOMAIN 15..104 FT /note="EH" FT /evidence="ECO:0000259|PROSITE:PS50031" FT DOMAIN 48..83 FT /note="EF-hand" FT /evidence="ECO:0000259|PROSITE:PS50222" FT DOMAIN 128..216 FT /note="EH" FT /evidence="ECO:0000259|PROSITE:PS50031" FT DOMAIN 160..195 FT /note="EF-hand" FT /evidence="ECO:0000259|PROSITE:PS50222" FT DOMAIN 223..258 FT /note="EF-hand" FT /evidence="ECO:0000259|PROSITE:PS50222" FT DOMAIN 224..314 FT /note="EH" FT /evidence="ECO:0000259|PROSITE:PS50031" FT REGION 536..607 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 668..692 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 732..849 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COILED 335..474 FT /evidence="ECO:0000256|SAM:Coils" FT COMPBIAS 536..568 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 584..603 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 668..690 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 732..752 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 767..791 FT /note="Pro residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 826..849 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" SQ SEQUENCE 897 AA; 98613 MW; 8AC00E465C9DB8D7 CRC64; MAAAAQLSLT QLSSGNPVYE KYYRQVEAGN TGRVLALDAA AFLKKSGLPD LILGKIWDLA DTDGKGVLNK QEFFIALRLV ACAQNGLEVS LSSLNLAVPP PRFHDSSSPL LTSGTSVAEL PWAVKSEDKA KYDAIFDSLS PVDGFLSGDK VKPVLLNSKL PVEILGRVWE LSDIDHDGKL DRDEFAVAMF LVYCALEKEP VPMSLPPALV PPSKRKTWVV SPAEKAKYDE IFLKTDKDMD GYVSGLEVRE TFLKTGLPST LLAHIWALCD TKNCGKLSKD QFALAFHLIN QKLIKGIDPP HSLTPEMIPP SDRSSLQKNT IGSSPVADFS AIKELDTLNN EIIDLQREKN NVEQDLKEKE DTVRQRTTEA QDLQDEVQRE SLNLQKLQAQ KQQVQELLDE LDEQKAQLEE QLKEVRKKCA EEAQLISSLK AEITSQESQI STYEEELSKA REELSRLQQE TAQLEESVES GKAQLEPLQQ HLQDSQQEIS SMQMRLAMKD LETDNNQSNW CSSPQSILVN GAADYCSLST SSSETANLNE HAEGQNNLES EPIHPESSVR SSPEIAPSDV TDESEVVTAA DIEKVSPRFD DDKHSKEEDP FNVESSSLTD AVADTNLDFF QSDPFVGSDP FKDDPFGKID PFGGDPFKGS DPFASDCFFK QTSTDPFATS STDPFSASSN SSNTSVETWK HNDPFAPGGT VVAATDSATD PFASVFGNES FGDGFADFST LSKVSNEDPF NPTISSSASS VVIPKPVLEE TPSKSEDVPP ALPPKTGTPT RPCPPPPGKR PINKLDSSDP FKLNDPFQPF PGNDSPKEKD PDMFCDPFTS SSTTANKEAE PSNFANFSAY PSEEDMIEWA KRESEREEEQ RLARLNQQEQ EDLELAIALS KSEISEA //